KIAA1618 inhibitors represent a specific category of small molecules or compounds that are designed to selectively bind to and modulate the activity of the KIAA1618 protein. KIAA1618 is a relatively underexplored protein with emerging significance in cellular processes. The inhibitors in this chemical class generally function by interacting with the active sites or allosteric regions of the KIAA1618 protein, thereby preventing it from carrying out its normal biochemical functions. Structurally, these inhibitors may vary, but they often exhibit key functional groups capable of forming specific non-covalent interactions, such as hydrogen bonds or van der Waals forces, with the protein target. These interactions are crucial for ensuring the high specificity and potency of the inhibitors, which are often evaluated in vitro through enzymatic assays that measure their capacity to alter KIAA1618 activity.
From a biochemical standpoint, KIAA1618 inhibitors can be useful tools in studying the mechanistic role of KIAA1618 within broader cellular pathways. Researchers can utilize these inhibitors to dissect the function of the protein in various signaling networks, particularly those related to cell proliferation, differentiation, and apoptosis. By inhibiting KIAA1618, scientists can observe shifts in cellular phenotypes, gene expression patterns, or protein interaction landscapes, helping to elucidate its role in molecular biology. Additionally, the structural analysis of KIAA1618 bound to its inhibitors can offer insights into protein-ligand interactions, which are fundamental for understanding how small molecules can modulate the function of previously uncharacterized proteins. This can also lead to a deeper understanding of protein conformational dynamics and regulatory mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, which could affect downstream signaling pathways where KIAA1618 may play a role. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor, which could also impact signaling cascades involving KIAA1618. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAP kinase, potentially altering stress response pathways that KIAA1618 may influence. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which is upstream of ERK; could affect pathways regulating cell proliferation involving KIAA1618. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, modulating apoptosis pathways that KIAA1618 might affect. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, which could impact cellular growth and metabolism pathways involving KIAA1618. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibits ROCK, potentially affecting cytoskeletal remodeling where KIAA1618 might play a role. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
Src family kinase inhibitor, which could alter cell adhesion or migration pathways involving KIAA1618. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
A broad spectrum kinase inhibitor, could impact various signaling pathways that include KIAA1618. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Inhibits Bcr-Abl and other kinases, potentially affecting signaling networks where KIAA1618 is active. | ||||||